Twitter LinkedIn
    Wednesday, March 29
    Login
    0 Shopping Cart
    Twitter LinkedIn
    Private Equity InsiderPrivate Equity Insider
    • About Us
    • Digital Events
    • Our Network
      • Reach
      • Sponsors
      • Members
    Private Equity InsiderPrivate Equity Insider
    Home»Deals & Transactions»BioAgilytix secures new investment from Cinven
    Deals & Transactions

    BioAgilytix secures new investment from Cinven

    November 19, 2021Updated:November 19, 20211 Min Read
    LinkedIn Facebook Twitter Email WhatsApp
    Share
    LinkedIn Facebook Twitter Email WhatsApp

    Buyout firm Cinven secures a deal to acquire BioAgilytix in a transaction valuing the drug-research services company at more than $2.5 billion, according to people familiar with the matter. 

    Cinven beat out a number of other private equity firms in the highly competitive bidding process, the people said. The deal values BioAgilytix at more than 30 times its estimated earnings before interest, taxes, depreciation and amortization, the people said. The company generates roughly $75 million of annual profit on that basis, they said. 

    BioAgilytix provides large molecule bioanalytical testing services, with locations in Durham, North Carolina as well as Boston and Hamburg, according to its website. Its customers include Gilead Sciences Inc., Novartis AG and Biogen Inc. 

    Read more/Source: Bloomberg

    Related

    Can't stop reading? This and all news articles are property of their creators, many are not owned or provided by Private Equity Insider. As an event organizer and community platform, we curate content from reliable sources for your suggested reading, and advise you to read the full articles from the referenced authors and sources.

    Acquisitions PE Insider
    Share. LinkedIn Facebook Twitter Email WhatsApp

    Related Posts

    Thyssenkrupp shares move higher on report of CVC interest in steel unit

    March 21, 2023

    BlackRock Not Working on Rival Bid for Credit Suisse

    March 18, 2023

    University of California invests $4 bn in redemption-stricken REIT

    January 3, 2023

    Euroclear moves into $9.8 trillion private asset market with Goji buy

    December 21, 2022

    Comments are closed.

    Other Articles

    Dr Martens will make stock market debut at value of £3.7bn

    February 4, 2021

    Carlyle leads $312 million funding round for Japanese unicorn Spiber

    September 8, 2021

    Private Equity-backed Breitling CEO eyes deals after turnaround

    October 4, 2022

    Panoramic Ventures Gains Momentum with Expansion of Leadership Team

    March 26, 2021

    Private Equity Insider LLC
    1212 Avenue of the Americas
    New York City 10036
    USA

    [email protected]

    Twitter LinkedIn
    © 2023 Private Equity Insider LLC. All rights reserved.
    • About
    • Terms of Use
    • Cookie Policy
    • Privacy Policy
    • Contact Us

    Type above and press Enter to search. Press Esc to cancel.

    View Cart Checkout Continue Shopping

    Sign In or Register

    Welcome Back!

    Login to your account below.


    Lost password?